Industry

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth, a global healthcare and specialty pharmacy solutions company, is pleased to be recognized as part of The Financial Times’ list of “Americas’ Fastest Growing Companies 2022,” a prestigious award presented by The Financial Times and Statista Inc., the world-leading statistics portal and industry ranking provider. This award goes to enterprises that contribute … [Read more…]

Council to implement InnovateOhio GCT strategy to accelerate category momentum in Ohio COLUMBUS, Ohio–(BUSINESS WIRE)–#Ohio–BioOhio, the state’s bioscience trade organization, today announced the creation of a Gene and Cell Therapy Industry Council to amplify industry support for the growing momentum of this category across the state of Ohio. Gene and cell therapies represent some of … [Read more…]

BOSTON–(BUSINESS WIRE)–#ElderLaw–The Massachusetts Chapter of the National Academy of Elder Law Attorneys (MassNAELA) celebrates May as Elder Law Month by working to empower residents of the Commonwealth to receive care in their home as they age. Many Massachusetts residents are forced to leave their home to receive care, because they do not have the resources … [Read more…]

The RFID-enabled, tilt-monitoring product helps deter damage throughout the supply chain DALLAS–(BUSINESS WIRE)–SpotSee®, a global leader in supply chain indicators that protect products against damage and ensure supply chain integrity, has expanded its TiltWatch product line to include an indicator that combines tilt-monitoring capabilities with passive radio-frequency identification (RFID) technology. The new TiltWatch® RFID alerts … [Read more…]

More than a third operating on assumptions rather than on real-time information CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nearly nine of ten – a whopping 86% — of business leaders at financial services companies aren’t confident that their data can be used for decision-making, according to research commissioned by InterSystems. The study of more than 550 business leaders across … [Read more…]

COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a digital health leader revolutionizing chronic care, today announced that it was Certified™ by Great Place to Work®. The prestigious award is based entirely on feedback from current employees regarding their experience working at Welldoc. This year, 95 percent of employees said Welldoc is a great place to work – 36 points … [Read more…]

 Veteran Boston Air Personality Adam 12 to Emcee Fundraiser Supporting Pediatric Cancer Treatments BOSTON–(BUSINESS WIRE)–#AI–Hack/Reduce, a non-profit focused on creating talent and technologies for Boston’s big data-driven economy, today announced that Beasley Media Group’s WBOS (ROCK 92.9) is an official media partner of Tech Tackles Cancer’s (TTC) charity event being held on June 21, 2022, … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that management will be presenting a corporate overview and participating in 1-on-1 meetings at the upcoming H.C. Wainwright Global Investment Conference May 23-25, 2022. H.C. Wainwright Global Investment Conference Presentation (hybrid) Date: Tuesday, … [Read more…]

Expanded Distribution, Entry into New Geographic Markets and Regulatory Approvals Advancing Efforts Towards Full Commercialization ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today reported its financial results for the quarter ended March 31, 2022. First Quarter 2022 Financial and … [Read more…]

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, open-label, proof-of-concept trial to evaluate its development-stage medicine daxdilimab (HZN-7734), a potentially first-in-class, fully human monoclonal antibody targeting immunoglobulin-like transcript 7 (ILT7), to treat people with moderate-to-severe alopecia areata. Alopecia areata is a common, acute onset autoimmune disorder … [Read more…]